GlassScriptPhysician profile
Raul Holguin
NPI 1295733178
$3,807.67
in general payments reported to CMS, 2019-2025
33 companies · $365 in 2025
The $365 reported for 2025 was more than what a typical Family Medicine provider received nationally (typical 2025 total: $153).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,266 · 2020: $197 · 2022: $865 · 2023: $441 · 2024: $673 · 2025: $365.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,479.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,479.39 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boston Scientific Corporation | $519.09 | 2022-2024 | Watchman Access System |
| Glaxosmithkline, LLC. | $378.98 | 2019-2025 | Trelegy Ellipta, Arexvy |
| Novo Nordisk INC | $339.66 | 2019-2025 | Rybelsus, Ozempic, Wegovy |
| Amgen INC. | $291.63 | 2019-2025 | Repatha, Otezla, Repatha |
| Astrazeneca Pharmaceuticals LP | $276.41 | 2019-2025 | Airsupra, Evusheld |
| Bayer Healthcare Pharmaceuticals INC. | $263.85 | 2022-2024 | |
| Lilly USA, LLC | $224.37 | 2019-2025 | Mounjaro, Jardiance, Zepbound |
| Pfizer INC. | $203.31 | 2019-2024 | |
| Merck Sharp & Dohme LLC | $188.82 | 2019-2025 | Gardasil 9, Capvaxive, Vaxneuvance |
| Boehringer Ingelheim Pharmaceuticals, INC. | $144.01 | 2019-2023 | Jardiance |
| Astellas Pharma US INC | $140.89 | 2019-2025 | Veozah |
| Exact Sciences Corporation | $82.94 | 2024-2025 | Cologuard Collection Kit, The Cologuard Plus Collection Kit |
| Sanofi-Aventis U.S. LLC | $67.23 | 2019 | |
| Kowa Pharmaceuticals America, INC. | $65.18 | 2019-2022 | |
| Janssen Pharmaceuticals, INC | $64.25 | 2020-2024 | Xarelto |
Show all 33 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Takeda Pharmaceuticals U.S.A., INC. | $61.43 | 2019 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $52.25 | 2019-2025 | Xifaxan |
| Abbvie INC. | $50.03 | 2022-2025 | |
| Xeris Pharmaceuticals, INC. | $46.81 | 2022 | |
| Amarin Pharma, INC. | $42.49 | 2019-2020 | |
| Biohaven Pharmaceutical Holding Company LTD. | $41.44 | 2022 | |
| Phathom Pharmaceuticals, INC. | $38.77 | 2024 | Voquezna |
| Medtronic USA, INC. | $34.86 | 2020 | |
| Sunovion Pharmaceuticals INC. | $28.00 | 2019 | |
| Allergan, INC. | $23.63 | 2019 | |
| Tandem Diabetes Care, INC. | $23.07 | 2022 | |
| Abbott Laboratories | $21.99 | 2022 | |
| Antares Pharma, INC. | $18.76 | 2019 | |
| Otsuka America Pharmaceutical, INC. | $17.69 | 2022 | |
| Dexcom, INC. | $14.66 | 2024 | Dexcom G6 Transmitter |
| Idorsia Pharmaceuticals US INC | $14.31 | 2023 | Quviviq |
| Nalpropion Pharmaceuticals LLC | $13.74 | 2019 | |
| E.R. Squibb & Sons, L.L.C. | $13.12 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Raul Holguin listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.